MeSH Browser

MeSH Supplementary: CEO-PE protocol
Unique ID: C089256
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C089256
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Vincristine; Epirubicin; Carboplatin
Frequency: 1
Note: a chemotherapy protocol consisting of above compounds; used for treatment of patients with limited stage small cell lung cancer
Source: Lung Cancer 1993 Dec;10(3-4):199-208
Date of Entry: 1994/10/04
Revision Date: 2000/11/30

CEO-PE protocol MeSH Supplementary Concept Data 2025